Results presented at the 85th Scientific Sessions of the American Diabetes Association in Chicago highlight the potential for ...

TUESDAY, June 24, 2025 (HealthDay News) — A single infusion of a new stem cell-based treatment may have helped 10 out of 12 ...

Vertex Pharmaceuticals' stem cell therapy, Zimislecel, has shown potential to cure Type-1 diabetes, achieving insulin independence in 83% of patients during clinical trials.

Translational Therapeutics Accelerator (TRxA) proudly announced today a $250,000 grant award aimed at developing a novel ...

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit ...